FDC
|
The Current P/S Ratio of FDC is 3.30.
| Share Price | ₹420.9 | Dec 15,2025 |
| Market Cap | ₹6,851.4 Cr | |
| Sales-TTM | ₹2,077.4 Cr | TTM-Consolidated Results |
| Price/Sales | 3.30x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of FDC
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹6,851.4 Cr] as on Dec 15,2025
(/) Sales [ ₹2,077.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.30x ]
Thus, for FDC , the investors are currently willing to pay '3.30 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of FDC !
The chart below summarizes the trend in P/S Ratio of FDC over the last five years.
Historical PS (Price/Sales) ratio chart of FDC
PS Ratio Performance Analysis for FDC
- FDC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.09x.
- FDC 's operated at median p/e ratio of 3.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/e ratio peaked in Mar2021 at 3.62x.
- FDC 's p/e ratio hit its five-year low in Mar2023 of 2.39x.
How does FDC 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| FDC | 2,077.4 | 3.30 | 6,851.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.85 | 431,220.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.80 | 168,486.0 |
| CIPLA LTD | 28,349.6 | 4.29 | 121,751.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.45 | 127,963.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.11 | 106,866.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.52 | 88,460.0 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.78 | 92,699.3 |
| LUPIN LTD | 24,750.7 | 3.86 | 95,477.8 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.12 | 68,854.0 |
| ABBOTT INDIA LTD | 6,714.4 | 8.83 | 59,275.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs FDC 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.12x |
| Max industry PS | 16.80x |
| Median industry PS | 4.29x |
| Average industry PS | 6.45x |
You may also like the below Video Courses